Company: CI
Filing Date: 2025-07-31
Form Type: 10-Q
Source: 0001739940-25-000028
Chunk: 157

Company: Cigna Group
Filing Date: 2025-07-31
Form: 10-Q
Item: Part II, Item 7
Chunk 157
---
 investment (gains) losses (1)$(0.36)(0.38)$(0.02)(0.07)$(0.53)(0.56)$6.36 6.30 Amortization of acquired intangible assets1.57 1.23 1.48 1.11 3.12 2.47 2.94 2.23 Special itemsStrategic optimization program0.48 0.37 — — 1.27 0.97 — — Integration and transaction-related costs0.28 0.21 0.22 0.17 1.07 0.81 0.34 0.26 (Gain) loss on sale of businesses — — — — (0.15)(0.43)0.07 (0.15)Deferred tax expenses, net (2)— 0.06 — 0.06 — 0.13 — 0.12 Total special items$0.76 0.64 $0.22 0.23 $2.19 1.48 $0.41 0.23 Adjusted income from operations$7.20 $6.72 $13.94 $13.19 

(1) Includes Net investment gains/losses as presented in our Consolidated Statements of Income, as well as the Company's share of certain investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting, which are presented within Fees and other revenues in our Consolidated Statements of Income.

(2) Represents amortization of a foreign tax attribute. See Note 20 to the Consolidated Financial Statements in our 2024 Form 10-K for additional details.

35

Financial highlights by segmentThree Months Ended June 30,Six Months Ended June 30,(Dollars in millions, except per share amounts)20252024Change20252024ChangeRevenuesAdjusted revenues by segmentEvernorth Health Services$57,825 $49,548 17 %$111,506 $95,774 16 %Cigna Healthcare10,754 13,143 (18)25,236 26,420 (4)Other Operations184 227 (19)359 393 (9)Corporate, net of eliminations(1,629)(2,448)(